Role of Platelets and Leukocytes in Modulation of Vascular Tonea
- 1 April 1994
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 714 (1) , 122-135
- https://doi.org/10.1111/j.1749-6632.1994.tb12036.x
Abstract
Activated platelets and leukocytes release potent vasoactive factors that may modulate vascular tone. Activation of normal platelets produces dilatation of normal arteries. Vasodilatation is mediated by adenosine diphosphate (ADP), which releases endothelium-derived relaxing factor (EDRF) from endothelium. In atherosclerotic arteries, activation of platelets produces constriction and perhaps spasm. The constrictor response of atherosclerotic arteries is related in part to profound changes in vascular function: endothelial dysfunction with impaired endothelium-dependent vasodilator responses to ADP, and augmented vasoconstrictor responses to serotonin. In addition, hypercholesterolemia has a direct effect on platelets, resulting in impaired vasodilator responses. Thus, abnormal platelets and altered vascular function may both predispose to spasm of atherosclerotic arteries. Activation of leukocytes has little effect on resistance of large arteries in normal monkeys. In contrast, activation of leukocytes produces pronounced vasoconstriction in atherosclerotic monkeys. Possible mediators of vasoconstriction include prostaglandin E2, oxygen radicals, thromboxane, and a peptide (perhaps angiotensin II). In addition, leukocytes also alter vascular responses to platelets, in part by ADPase on the leukocyte membrane, which degrades ADP released by activated platelets. Leukocytes also release oxygen radicals, which may inactivate EDRF, thereby impairing ADP-mediated, endothelium-dependent vasodilator responses. Abnormal responses to platelets and leukocytes are largely reversed when atherosclerotic lesions regress in monkeys.Keywords
This publication has 57 references indexed in Scilit:
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Vascular responses to platelet activation in normal and atherosclerotic primates in vivo.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.Circulation, 1989
- Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids.Circulation Research, 1988
- Leukocytes and the risk of ischemic diseasesPublished by American Medical Association (AMA) ,1987
- Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides.Journal of Clinical Investigation, 1986
- Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Platelets, endothelium, and vasospasm.Circulation, 1985
- Vessel injury, platelet adherence, and platelet survival.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- The Leukocyte Count as a Predictor of Myocardial InfarctionNew England Journal of Medicine, 1974